Northwell Health: Glioblastoma trials

The registry lists 16 Glioblastoma studies with Northwell Health as lead sponsor. 7 are open to participants now and 2 have results posted.

Phase 1 10Phase 2 7Phase 3 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)RecruitingNCT05979064Not applicable
• Surgical Tissue Flap to Bypass the Blood Brain Barrier in GlioblastomaRecruitingNCT05954858Not applicable
• Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBMRecruitingNCT05271240Phase 3
• Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBMRecruitingNCT03213002Phase 1/2
• Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed GlioblastomaRecruitingNCT02861898Phase 1/2
• Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOARecruitingNCT02800486Phase 2
• Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AARecruitingNCT01269853Phase 1/2
• Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBMCompletedNCT01811498Phase 1/2Results posted
• Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic AstrocytomaCompletedNCT00301418Phase 1/2Results posted
• Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)SuspendedNCT04222309Phase 1
• Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant GliomasWithdrawnNCT03956706Not applicable
• Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBMCompletedNCT03630289Not applicable
• Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic AstrocytomaSuspendedNCT01386710Phase 1/2
• Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AACompletedNCT01238237Phase 1
• Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AACompletedNCT01180816Phase 1
• Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)CompletedNCT00968240Phase 1